ASO Author Reflections: Quality-of-Life Trajectories After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Ann Surg Oncol. 2020 Oct;27(10):3995-3996. doi: 10.1245/s10434-020-08448-z. Epub 2020 Apr 15.

Authors

Daniel Steffens^{1

2}, Brendan Moran³

Affiliations

¹ Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital (RPAH), Sydney, NSW, Australia. [email protected].
² Faculty of Medicine and Health, The University of Sydney, Sydney, Australia. [email protected].
³ Peritoneal Malignancy Institute, Basingstoke, Basingstoke, UK.

PMID: 32297085
DOI: 10.1245/s10434-020-08448-z

No abstract available

MeSH terms

Combined Modality Therapy
Cytoreduction Surgical Procedures
Humans
Hyperthermic Intraperitoneal Chemotherapy*
Peritoneal Neoplasms* / drug therapy
Peritoneal Neoplasms* / therapy
Quality of Life